Stay updated on BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    No significant additions or deletions detected; the Study Details page content appears unchanged across screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:14:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T10:09:13.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated the page from revision v3.0.2 to v3.1.0, signaling a new release version.
    Difference
    0.1%
    Check dated 2025-09-28T03:12:34.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing the previous Revision: v3.0.1. The Back to Top element has been removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:15:54.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T14:38:23.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, particularly in Russia and Belarus, while removing several previous location entries and related terms. The revision number has also been updated from v2.16.12 to v3.0.0.
    Difference
    8%
    Check dated 2025-08-30T11:22:54.000Z thumbnail image

Stay in the know with updates to BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BCD-022 vs Herceptin in HER2+ Metastatic Breast Cancer Clinical Trial page.